CA1034572A - Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine - Google Patents

Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine

Info

Publication number
CA1034572A
CA1034572A CA214,716A CA214716A CA1034572A CA 1034572 A CA1034572 A CA 1034572A CA 214716 A CA214716 A CA 214716A CA 1034572 A CA1034572 A CA 1034572A
Authority
CA
Canada
Prior art keywords
ergopeptine
dihydro
beta
benzyl
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA214,716A
Other languages
English (en)
Inventor
Theodor Fehr
Paul Stadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1034572A publication Critical patent/CA1034572A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
CA214,716A 1973-11-28 1974-11-27 Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine Expired CA1034572A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1669873A CH587858A5 (fr) 1973-11-28 1973-11-28

Publications (1)

Publication Number Publication Date
CA1034572A true CA1034572A (fr) 1978-07-11

Family

ID=4419482

Family Applications (1)

Application Number Title Priority Date Filing Date
CA214,716A Expired CA1034572A (fr) 1973-11-28 1974-11-27 Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine

Country Status (25)

Country Link
US (1) US4229451A (fr)
JP (1) JPS5919116B2 (fr)
AT (1) AT352911B (fr)
BE (1) BE822729A (fr)
CA (1) CA1034572A (fr)
CH (1) CH587858A5 (fr)
CS (1) CS176291B2 (fr)
DD (1) DD115119A5 (fr)
DE (1) DE2454619A1 (fr)
DK (1) DK143804C (fr)
ES (1) ES432288A1 (fr)
FI (1) FI59254C (fr)
FR (2) FR2252098B1 (fr)
GB (2) GB1496491A (fr)
HK (1) HK54080A (fr)
HU (1) HU168859B (fr)
IE (1) IE41767B1 (fr)
IL (1) IL46128A (fr)
MY (1) MY8100185A (fr)
NL (1) NL7415250A (fr)
NO (1) NO744175L (fr)
PH (1) PH13669A (fr)
SE (2) SE417319B (fr)
SU (1) SU516355A3 (fr)
ZA (1) ZA747603B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US20070197576A1 (en) * 2006-02-08 2007-08-23 Resolution Chemicals Limited Production of Cabergoline and Novel Polymorphic Form Thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2619488A (en) * 1952-11-25 Method of preparing d
GB769260A (en) * 1954-04-07 1957-03-06 Sandoz Ltd Process for the preparation of isomeric racemic dihydrolysergic acids and their homologues
DE1006425B (de) * 1954-04-07 1957-04-18 Sandoz Ag Verfahren zur Herstellung der isomeren racemischen Dihydrolysergsaeuren und ihren Homologen
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH469006A (de) * 1965-07-07 1969-02-28 Sandoz Ag Verfahren zur Herstellung neuer synthetischer Alkaloide
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
GB1298277A (en) * 1969-04-18 1972-11-29 Sandoz Ltd Preparation of ergot peptide alkaloids
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation

Also Published As

Publication number Publication date
ZA747603B (en) 1976-07-28
ATA945174A (de) 1979-03-15
DK143804C (da) 1982-03-29
IL46128A0 (en) 1975-02-10
FR2334681B1 (fr) 1980-04-18
FR2252098B1 (fr) 1978-06-30
IE41767L (en) 1975-05-28
DE2454619A1 (de) 1975-06-05
NL7415250A (nl) 1975-05-30
PH13669A (en) 1980-08-26
US4229451A (en) 1980-10-21
IE41767B1 (en) 1980-03-26
AT352911B (de) 1979-10-10
FR2252098A1 (fr) 1975-06-20
BE822729A (fr) 1975-05-28
JPS5919116B2 (ja) 1984-05-02
CH587858A5 (fr) 1977-05-13
FR2334681A1 (fr) 1977-07-08
FI334574A (fr) 1975-05-29
NO744175L (fr) 1975-06-23
FI59254C (fi) 1981-07-10
GB1496492A (en) 1977-12-30
SE417319B (sv) 1981-03-09
DK600374A (fr) 1975-07-28
ES432288A1 (es) 1977-02-16
SU516355A3 (ru) 1976-05-30
IL46128A (en) 1977-10-31
HK54080A (en) 1980-10-03
AU7582674A (en) 1976-05-27
SE7414607L (fr) 1975-05-29
DK143804B (da) 1981-10-12
HU168859B (fr) 1976-07-28
FI59254B (fi) 1981-03-31
SE7710418L (sv) 1977-09-16
CS176291B2 (fr) 1977-06-30
JPS5084599A (fr) 1975-07-08
DD115119A5 (fr) 1975-09-12
MY8100185A (en) 1981-12-31
SE424869B (sv) 1982-08-16
GB1496491A (en) 1977-12-30

Similar Documents

Publication Publication Date Title
IE39302L (en) 1,4- diazacycloheptanes.
CA1030951A (fr) 8.alpha.-OESTRATRIENES OXYGENES EN 1,3
CA1030950A (fr) 8.alpha.-OESTRATRIENES OXYGENES EN 1,3
CA1034572A (fr) Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine
CA1016176A (en) .alpha.-CYCLOALKYLBENZYL LACTAMIMIDES
CA1020544A (en) DERIVATIVES OF 7.alpha.-METHYLESTR-4-ENE-3.alpha., 17.beta.-DIOLS
CA1008076A (en) .alpha.-ALKYLBENZYL LACTAMIMIDES
CA1033716A (fr) 17b hydroxy-16, 16-dimethylestr-4-en-3-one
CA1027929A (fr) 7-alkyle-.delta.3,5-steroides
CA1003418A (en) 1,3-BIS(.beta.-ETHYLHEXYL)-5-AMINO-5-METHYLHEXAHYDROPYRIMIDINE-PYRIDINE-3-CARBOXYLATE AND PROCESS FOR THE PREPARATION THEREOF
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
CA1024140A (fr) Anilino-6 trihydroxyanthraquinones-1,4,5
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1008451A (en) PROCESS FOR THE PREPARATION OF 2,2'-ANHYDRO-1.beta.-D-ARABINOFURANOSYL-5-FLUOROCYTOSINE
CA1031335A (fr) Tetrahydro-6,7,8,9 1h-pyrazolo (3,4-b) (1,5) diazocines
CA1010861A (en) 9.beta.-HYDROXY-5-METHYL-6,7-BENZOMORPHANS
CA1031779A (fr) Thiadiazol-1,3,4-yl-2 urees a action herbicide specifique
CA992960A (en) 2,2'-anhydro-b-d-arabinofuranosyl-5-fluorocytosine
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
CA882103A (en) 11.beta.-HYDROXY-5.alpha.,6.alpha.-EPOXYSTEROIDE
CA866779A (en) 9.beta.,10.alpha.-STEROID
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
CA874963A (en) 3.alpha.,20-DIACYLOXY-16.beta.-ALKYL-17(20)-PREGNENE-11-ONE
CA882107A (en) 15.beta.,16.beta. METHYLENE-STEROID
CA879096A (en) 9.beta., 10.alpha.-STEROID INTERMEDIATES